Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
UBS
Johnson and Johnson
Merck
QuintilesIMS
Covington
Harvard Business School
Teva
Federal Trade Commission
AstraZeneca

Generated: February 22, 2018

DrugPatentWatch Database Preview

FAMOTIDINE - Generic Drug Details

« Back to Dashboard

What are the generic sources for famotidine and what is the scope of famotidine freedom to operate?

Famotidine
is the generic ingredient in eleven branded drugs marketed by Hi-tech Pharma Co, Lupin Ltd, Navinta Llc, Novel Labs Inc, Salix Pharms, Apotex Inc, Apothecon, Athenex Inc, Fresenius Kabi Usa, Hospira, Mylan Labs Ltd, West-ward Pharms Int, Abbvie, Baxter Hlthcare, Merck, Merck Sharp Dohme, Perrigo, J And J Consumer Inc, Ucb Inc, Actavis Elizabeth, Alembic Pharms Ltd, Apotex, Aurobindo Pharma Ltd, Carlsbad, Dr Reddys Labs Ltd, Ivax Sub Teva Pharms, Mylan, Mylan Pharms Inc, Perrigo R And D, Sandoz, Sun Pharm Inds Ltd, Sun Pharm Industries, Teva, Watson Labs, Wockhardt, Wockhardt Ltd, Valeant Pharms North, and Horizon Pharma, and is included in sixty-nine NDAs. There are nine patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Famotidine has sixteen patent family members in nine countries.

There are eighteen drug master file entries for famotidine. One hundred and eighteen suppliers are listed for this compound. There are five tentative approvals for this compound.
Pharmacology for FAMOTIDINE
Medical Subject Heading (MeSH) Categories for FAMOTIDINE
Tentative approvals for FAMOTIDINE
Applicant Application No. Strength Dosage Form
➤ Try a Free Trial➤ Try a Free Trial10MG/MLInjectable; Injection
➤ Try a Free Trial➤ Try a Free Trial10MG/MLInjectable; Injection
➤ Try a Free Trial➤ Try a Free Trial10MG/MLInjectable; Injection

US Patents and Regulatory Information for FAMOTIDINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo FAMOTIDINE famotidine TABLET, CHEWABLE;ORAL 075715-001 Aug 22, 2003 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Elizabeth FAMOTIDINE famotidine TABLET;ORAL 075650-002 Sep 14, 2001 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sun Pharm Inds Ltd FAMOTIDINE famotidine TABLET;ORAL 090283-001 Nov 17, 2009 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novel Labs Inc FAMOTIDINE famotidine FOR SUSPENSION;ORAL 201695-001 Dec 17, 2012 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Dr Reddys Labs Ltd FAMOTIDINE famotidine TABLET;ORAL 077367-001 Sep 25, 2006 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan FAMOTIDINE famotidine TABLET;ORAL 075674-001 Dec 21, 2001 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Perrigo R And D FAMOTIDINE famotidine TABLET;ORAL 077351-001 Sep 25, 2006 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Horizon Pharma DUEXIS famotidine; ibuprofen TABLET;ORAL 022519-001 Apr 23, 2011 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Ucb Inc FLUXID famotidine TABLET, ORALLY DISINTEGRATING;ORAL 021712-001 Sep 24, 2004 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Valeant Pharms North PEPCID famotidine TABLET;ORAL 019462-002 Oct 15, 1986 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for FAMOTIDINE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck PEPCID RPD famotidine TABLET, ORALLY DISINTEGRATING;ORAL 020752-002 May 28, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020325-001 Apr 28, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Salix Pharms PEPCID famotidine FOR SUSPENSION;ORAL 019527-001 Feb 2, 1987 ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER famotidine INJECTABLE;INJECTION 020249-001 Feb 18, 1994 ➤ Try a Free Trial ➤ Try a Free Trial
J And J Consumer Inc PEPCID AC famotidine TABLET, CHEWABLE;ORAL 020801-002 Dec 17, 2007 ➤ Try a Free Trial ➤ Try a Free Trial
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020902-001 Aug 5, 1999 ➤ Try a Free Trial ➤ Try a Free Trial
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020325-001 Apr 28, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Merck PEPCID RPD famotidine TABLET, ORALLY DISINTEGRATING;ORAL 020752-002 May 28, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
J And J Consumer Inc PEPCID AC famotidine TABLET, CHEWABLE;ORAL 020801-001 Sep 24, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
J And J Consumer Inc PEPCID AC famotidine TABLET, CHEWABLE;ORAL 020801-001 Sep 24, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for FAMOTIDINE

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Cerilliant
Chinese Patent Office
Queensland Health
Julphar
Dow
Fuji
QuintilesIMS
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot